The Value of Ultrasound for Detecting and Following Subclinical Interstitial Lung Disease in Systemic Sclerosis
Tomography · 2024
DOI: 10.3390/tomography10040041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tomography, 2024. Verfasst von Marwin Gutierrez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence in Rheumatic and Musculoskeletal Disorders, Mexico City 03530, Mexico. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Scleroderma, Systemic, Ultrasonography, Tomography, X-Ray Computed. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Interstitial lung disease (ILD) is a complication in patients with systemic sclerosis (SSc). Accurate strategies to identify its presence in early phases are essential. We conducted the study aiming to determine the validity of ultrasound (US) in detecting subclinical ILD in SSc, and to ascertain its potential in determining the disease progression.
Methods
133 patients without respiratory symptoms and 133 healthy controls were included. Borg scale, Rodnan skin score (RSS), auscultation, chest radiographs, and respiratory function tests (RFT) were performed. A rheumatologist performed the lung US. High-resolution CT (HRCT) was also performed. The patients were followed every 12 weeks for 48 weeks.
Results
A total of 79 of 133 patients (59.4%) showed US signs of ILD in contrast to healthy controls (4.8%) (p = 0.0001). Anti-centromere antibodies (p = 0.005) and RSS (p = 0.004) showed an association with ILD. A positive correlation was demonstrated between the US and HRCT findings (p = 0.001). The sensitivity and specificity of US in detecting ILD were 91.2% and 88.6%, respectively. In the follow-up, a total of 30 patients out of 79 (37.9%) who demonstrated US signs of ILD at baseline, showed changes in the ILD score by US.
Conclusions
US showed a high prevalence of subclinical ILD in SSc patients. It proved to be a valid, reliable, and feasible tool to detect ILD in SSc and to monitor disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Excellence in Rheumatic and Musculoskeletal Disorders, Mexico City 03530, Mexico.
- Division of Rheumatology, Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra Ibarra, Mexico City 03530, Mexico.
- Pneumology Department, Unidad Medica de Alta Especialidad, 1 Bajio, Leon 37680, Mexico.
ORCID-Profile: Denise Clavijo-Cornejo
Zitieren
APA
Gutierrez, M., Bertolazzi, C., Zozoaga-Velazquez, E., & Clavijo-Cornejo, D. (2024). The Value of Ultrasound for Detecting and Following Subclinical Interstitial Lung Disease in Systemic Sclerosis. Tomography. https://doi.org/10.3390/tomography10040041
Vancouver
Gutierrez M, Bertolazzi C, Zozoaga-Velazquez E, Clavijo-Cornejo D. The Value of Ultrasound for Detecting and Following Subclinical Interstitial Lung Disease in Systemic Sclerosis. Tomography. 2024. doi:10.3390/tomography10040041
BibTeX
@article{Gutierrez2024,
author = {Gutierrez, Marwin and Bertolazzi, Chiara and Zozoaga-Velazquez, Edgar and Clavijo-Cornejo, Denise},
title = {The Value of Ultrasound for Detecting and Following Subclinical Interstitial Lung Disease in Systemic Sclerosis},
journal = {Tomography},
year = {2024},
doi = {10.3390/tomography10040041}
}
EUVIMED